Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Washington State offers a wide range of paid volunteering opportunities for both healthy participants and those looking for condition-specific clinical studies. Key centers in Seattle, Spokane, and Tacoma are actively recruiting participants, providing access to advanced medical treatments and innovative care solutions.
Filter
1
Filter results
Results: 1,593
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
for
GRIN-related Neurodevelopmental Disorder
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: GRIN Therapeutics, Inc.
Sex: All
Age: 0 - 18
Code: NCT07224581
Phase3, Recruiting
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
for
Solid Tumours
Location: Pittsburgh PA, Sioux Falls SD, Fort Worth TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07160725
Phase1, Phase2, Recruiting
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: Trenton NJ, Norfolk VA, Richmond VA, Sunrise FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07215559
Phase2, Recruiting
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
for
Bladder Cancer, Recurrent Bladder Cancer,
Location: Chapel Hill NC, Tampa FL, Columbus OH, Nashville TN,
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT07225127
Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT06900595
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Westbrook ME, Burlington MA, New York NY,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase3, Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Providence RI, Norwich CT, Hartford CT, New Haven CT,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase3, Recruiting
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
for
Prostate Cancer (Adenocarcinoma),
Location: Boston MA, New York NY, Philadelphia PA, Madison WI,
Sponsor: Prostate Cancer Clinical Trials Consortium
Sex: Male
Age: 18+
Code: NCT06844383
Phase2, Recruiting
Clinical Pre-screening Protocol for Ovarian Cancer
for
Ovarian Cancer
Location: New York NY, Tampa FL, Atlanta GA, Oklahoma City OK,
Sponsor: Allarity Therapeutics
Sex: Female
Age: 18+
Code: NCT03877796
Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
for
Type 2 Diabetes
Location: Quebec, Montreal, Morehead City NC, Hollywood FL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07754461
Phase3, Recruiting
The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA
for
Regional Anesthesia, Burn, Skin Grafting
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT07221903
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Brewer ME, Rockport ME, Brunswick ME, South Portland ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase3, Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
for
Castration-Resistant Prostatic Cancer, Metastasis
Location: Sherbrooke, New York NY, Montreal, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06863272
Phase1, Phase2, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase3, Recruiting
Minima Stent System Post- Approval Study (PAS)
for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Boston MA, Charlottesville VA, Miami FL, Pittsburgh PA,
Sponsor: Renata Medical
Sex: All
Age: 0+
Code: NCT06828770
Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Lake Success NY, New York NY, Philadelphia PA, Ottawa,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase3, Recruiting
Non-invasive Prediction of EArly Cardiac rEjection